At all concentrations used, the CLL cell line was more sensitive to these compounds in a dose dependent manner by MTT (Fig. 3C) or Annexin-V analysis (Fig. 3D) than the stromal HS-5 cell line. Here, ANXA5 is linked to B-cell chronic lymphocytic leukemia.